glp 1 drugs alzheimer's Disappointing GLP-1 Results in Trial: Underscores Promise (and Limits) of Single-Agent Approaches Novo Nordisk's oral GLP-1 drug

It is one of the most abundant intracellular peptides in mammals and plays a central role in cell migration, angiogenesis, and tissue protection

In contrast, we found that these metabolomic alterations led to a reduction in the plasma level of different metabolites including uridine, thymine, carnosine, theophylline, aspartate, taurine, serine, glutamate, tryptophan, arginine, and 53 other metabolites in the acute patients compared to HCs ( Supplementary Figures 6A, B )

All three work through different pathways

Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese

Quinzii CM, Lopez LC

Kynurenines in the mammalian brain: when physiology meets pathology